SmallCaps
ASX:EPNPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

Epsilon Healthcare Ltd

$0.022
Day Range
$0.022 – $0.022
52 Week Range
$0.019 – $0.040
Volume
51.38K
Avg Volume (10D)
120.93K
Market Cap
$8.56M

Price Chart

OHLC · volume · moving averages

$0.022-$0.012 (-35.29%)over 6M
Hi$0.040Lo$0.019
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.022
Previous Close
$0.022
Day High
$0.022
Day Low
$0.022
52 Week High
$0.040
52 Week Low
$0.019

Valuation

Fundamental multiples

Market Cap
8.56M
Shares Outstanding
389.10M
Price to Book
4.36

Trading Activity

Volume & order book

Volume
51.38K
Value Traded
1.13K
Bid
$0.022 × 197,318
Ask
$0.023 × 373,718

Performance

Returns across timeframes

1 Day
0.00%
5 Day
0.00%
13 Week
0.00%
YTD
-33.33%

Technical Indicators

Momentum & moving averages

RSI (14)
47.15
50-Day SMA
$0.022

— From the desk

Latest News

Epsilon Healthcare partners with Valens to produce medicinal cannabis for global markets
Biotechnology

Epsilon Healthcare partners with Valens to produce medicinal cannabis for global markets

Epsilon Healthcare (ASX: EPN) will make its Queensland-based production facility available to Canadian medicinal cannabis maker The Valens Company under a long-term partnership designed to boost Valens’ regional profile. The agreement will give Valens access to Epsilon’s manufacturing expertise and offer Valens the opportunity to further its international expansion to GMP (good manufacturing practice) markets […]

Epsilon Healthcare appoints cannabis industry expert to leadership team
Industrials & Juniors

Epsilon Healthcare appoints cannabis industry expert to leadership team

Diversified global pharmaceuticals company Epsilon Healthcare (ASX: EPN) has appointed cannabis industry professional Edward Jones to the role of divisional manager (cannabis operations) responsible for the performance of its subsidiaries THC Pharma and Canndeo. Mr Jones has a leadership background spanning many senior roles within global pharmaceutical manufacturing and multi-national project environments. He has previously […]

Strategic review realises quarterly cost savings for Epsilon Healthcare
Industrials & Juniors

Strategic review realises quarterly cost savings for Epsilon Healthcare

Diversified pharmaceuticals company Epsilon Healthcare (ASX: EPN), formerly THC Global Group, has posted its first quarterly report since finalising a major strategic review of its operations late last year. The company said it has realised the bulk of the cost savings implemented following the review and reported a further reduction in net cash used in […]